All Cancer articles – Page 39
-
HSJ LocalNHS consortium challenges NHS England £80m contract decision
A consortium of NHS trusts have lodged a formal challenge against NHS England following its decision to hand a 10 year, £80m contract for PET CT scanning to a private company.
-
NewsNHS England delays access to NICE approved drug
Patients will be put at risk of developing cancer after NHS England was granted permission to delay access to a groundbreaking cure for hepatitis C, patient groups have warned.
-
NewsCancer drugs fund will need to cut more treatments, chair warns
Treatments available through the cancer drugs fund will have to continue being cut, the NHS England official in charge of the fund has said.
-
NewsCancer drugs fund receives surprise £60m boost
NHS England has announced a surprise £60m boost to the cancer drugs fund, bringing it up to £340m for 2015-16, even as it slashes the number of drugs available.
-
HSJ LocalTrust hopes for £6m income from new cancer unit
FINANCE: A West Midlands acute trust is hoping to generate £5.9m in extra income per year following the opening of a new £23m cancer treatment unit this month.
-
HSJ LocalClatterbridge to reconfigure cancer care after ‘resounding’ public support
STRUCTURE: A specialist cancer trust in Merseyside is pressing ahead with plans to build a new centre in Liverpool.
-
HSJ LocalNo evidence of 'systematic manipulation' of Colchester cancer data
There is no evidence of staff being told to manipulate cancer waiting times data at Colchester Hospital University Foundation Trust, an independent investigation commissioned by Monitor has found.
-
NewsAppeal finds NICE decision on £90k breast cancer drug 'unfair'
The impact of the government’s drug pricing deal on patient access to new medicines has been thrown into confusion after a pharmaceutical company’s appeal against the decision to ban routine NHS funding of one of its drugs was upheld.
-
-
-
HSJ LocalWhistleblowing review of cancer trust finds no evidence of 'serious failings'
WORKFORCE: A review into whistleblowing concerns at a North West cancer trust has found “no evidence” of serious failings but highlighted areas in need of improvement.
-
NewsNew NHS England partnership with pharma to speed up drug access
Government plans for closer working between the NHS and the pharmaceutical industry will make the new generation of precision medicines more affordable for the NHS, the minister for life sciences has said.
-
NewsKate Granger recognised at HSJ Awards
Kate Granger, the consultant geriatrician and inspirational campaigner for patient compassion, has received a special recognition award at the 2014 HSJ Awards.
-
NewsHunt: Transparency not targets will achieve 'world class' NHS
The NHS must adopt a different approach to performance management that focuses on the transparent provision of information rather than chasing targets or extra resource, the health secretary is due to say
-
NewsMorecambe Bay under fire on cancer screening services
A foundation trust has pledged to shake up the management of its breast screening unit after a probe found an “extremely poor” working environment that must be having an “impact on patient care”
-
NewsExpensive drugs to be cut from cancer drugs fund
NHS England is to start evaluating the cost effectiveness of medicines available through the cancer drugs fund in a bid to bring the budget under control
-
NewsRevealed: Bidders for £1.2bn cancer and end of life care contracts
The NHS and independent sector organisations which have reached the next stage of bidding for two huge contracts to run cancer and end of life care services in Staffordshire have been revealed
-
CommentSaatchi's Medical Innovation Bill is Branson-esque in its boldness
Experimental proposal prompts soul searching
-
NewsCancer drugs fund threatens NHS England's bottom line
The NHS commissioning system is forecast to miss its target surplus by £184m in 2014-15, with much of the overspend attributed to the cancer drugs fund
-
HSJ KnowledgeRoot out inequality in breast cancer care
Asian women in the UK have very high incidence of the disease